“The Potential of Rosuvastatin in Stabilizing Lipid Profile and Improving Clinical Outcomes in Covid-19 Patients with Coronary Heart Disease”, NMSJ, vol. 6, no. 1, pp. 54–65, Oct. 2021, doi: 10.20956/nmsj.v6i1.12243.